Epilepsy Birth Control Registry
EBCR
1 other identifier
observational
1,000
1 country
2
Brief Summary
Despite the importance of birth control to women of reproductive age, there has been little formal investigation of the safety and effectiveness of birth control methods in women with epilepsy. To remedy this, doctors from Harvard and Columbia University Medical Schools have developed a website that offers a survey to help us gain more knowledge and some educational material that will be updated regularly to provide the latest information. The ultimate goal is to develop guidelines for the selection of safe and effective birth control methods and to make sure that the best forms of birth control become available to women with epilepsy in all communities of our society. Go to www.epilepsybirthcontrolregistry.com take our survey and then catch up on the latest information about birth control for women with epilepsy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2010
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 31, 2010
CompletedFirst Posted
Study publicly available on registry
April 2, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedOctober 16, 2015
October 1, 2015
6.8 years
March 31, 2010
October 14, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of seizures on hormonal versus non-hormonal contraception, stratified by antiepileptic drug category
3 years
Study Arms (1)
Epilepsy
Cohort is comprised of women with epilepsy between 18 and 47.
Interventions
This is an observational study conducted by anonymous survey. There is no intervention.
Eligibility Criteria
Participants are women with epilepsy between the ages of 18 and 47.
You may qualify if:
- Women with Epilepsy between 18 and 47
You may not qualify if:
- Women without epilepsy
- Women under 18
- Women over 47
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Neuroendocrine Associates P.C.lead
- Columbia Universitycollaborator
Study Sites (2)
Neuroendocrine Associates P.C.
Wellesley, Massachusetts, 02481, United States
Columbia University Medical Center
New York, New York, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew G Herzog, M.D.,M.Sc.
Neuroendocrine Associates P.C.
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 31, 2010
First Posted
April 2, 2010
Study Start
March 1, 2010
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
October 16, 2015
Record last verified: 2015-10